液体活检市场正在经历强劲增长，推动因素包括技术进步和临床采用的增加。
| 2024市场规模 | 91 (十亿美元) |
| 2035市场规模 | 273.4 (十亿美元) |
| 年均增长率 (2025 - 2035) | 10.52% |
全球癌症的日益普遍成为全球液体活检市场行业的主要驱动力。随着癌症病例的增加，对早期检测和监测解决方案的需求也在加剧。液体活检提供了一种非侵入性的替代传统组织活检的方法，允许对循环肿瘤DNA进行分析。例如，世界卫生组织指出，到2040年，癌症病例预计将达到3000万。这一不断增长的患者群体可能会推动市场，预计到2024年全球液体活检市场将达到89亿美元，到2035年可能达到229亿美元。
在液体活检市场中，肿瘤学作为主要应用领域，显著影响整体市场动态，其66%的市场份额反映了癌症发病率的上升，以及对早期检测和个性化治疗方法的日益重视。相反，产前检测正迅速崛起，受到技术进步的推动，这些技术提高了准确性，并且期待父母对非侵入性产前检测选项的需求不断增长。市场的增长趋势主要是由于液体活检相较于传统组织活检的日益普及，因其微创特性和提供实时见解的能力。此外，技术进步、监管支持和医疗支出的增加等因素正在推动市场的扩展。此外，液体活检益处的认知提高也为产前检测和传染病应用创造了良好的环境。
肿瘤学：主导与产前检测：新兴
肿瘤学作为液体活检市场中的主导应用领域，其在癌症诊断和监测中的广泛应用，帮助制定精确的治疗策略。该领域受益于强大的技术创新，这些创新提高了癌症检测方法的灵敏度和特异性。相反，产前检测作为一个新兴领域，因其非侵入性特性而受到期待父母的青睐。其增长得益于NIPT（非侵入性产前检测）技术的进步，这些技术提高了检测基因异常的准确性，并为父母提供了安心。总的来说，这些领域展示了液体活检不断发展的格局，使其处于精准医学应用的前沿。
在液体活检市场中，分析的样本类型中，血液占据了69%的最大份额，因其在临床环境中广泛接受和应用于多种癌症。它作为检测循环肿瘤DNA的主要介质，使其成为非侵入性诊断的必要工具。紧随其后，尿液迅速崛起，受到其微创采集方法和在早期癌症检测系统中日益普及的推动。
血液（主导）与尿液（新兴）
血液样本类型在液体活检市场中仍然占主导地位，因为它通过循环肿瘤细胞和游离DNA促进了肿瘤动态的全面分析。它在肿瘤学中的既定角色和与各种技术的兼容性巩固了其地位。另一方面，尿液作为一种新兴样本类型，因检测技术的创新而获得关注。其采集的便利性使其在患者依从性和大规模筛查中具有吸引力，特别是对于膀胱癌和其他泌尿系统恶性肿瘤。随着研究的进展，基于尿液的液体活检预计将在血液基方法旁开辟出一个重要的市场细分。
在液体活检市场中，按技术细分显示，下一代测序（NGS）占据了61%的最大市场份额，得益于其在基因组分析和高通量筛选方面的先进能力。数字PCR紧随其后，作为一个重要竞争者，满足了对DNA精确定量的需求，使其在有效监测治疗反应中至关重要。同时，微流体技术、质谱和循环肿瘤细胞技术等其他技术也发挥着重要作用，但在整体市场中占据较小份额。
下一代测序（主导）与数字PCR（新兴）
由于能够快速分析大量基因组信息，下一代测序（NGS）在液体活检市场中处于领先地位，使早期癌症检测和个性化医学成为可能。其技术进步使其成为研究人员和临床医生的首选。相反，数字PCR作为一种新兴技术，因其在定量稀有突变方面的灵敏度和特异性而受到青睐，这在治疗监测和疾病进展评估中至关重要。随着医疗保健强调精准医学，预计数字PCR的吸引力将因其在检测低丰度靶标方面的优越表现而显著增长。
在液体活检市场中，医院在最终用户中占据了58%的最大份额，得益于其在患者护理和先进诊断技术方面的综合能力。它们作为进行液体活检程序的中心枢纽，导致测试量最高。相反，诊断实验室正在经历快速增长，受到对及时和准确癌症诊断需求增加的推动，导致服务提供和实验室环境中的技术进步显著增加。
医院（主导）与诊断实验室（新兴）
医院在液体活检市场中发挥着主导作用，因为它们提供综合医疗服务和即时患者护理，这增强了液体活检测试的采用。它们为复杂诊断提供的既定基础设施支持了创新癌症检测解决方案的蓬勃发展。另一方面，诊断实验室作为关键参与者正在崛起，受益于其专注于检测和分析的专业化。这一领域正在迅速发展，以纳入先进技术，以满足对精准和高效诊断服务日益增长的需求。随着更多实验室投资于进行液体活检的能力，它们将自身定位为市场扩展的重要贡献者。
液体活检市场规模预计到2035年将达到273.4亿美元，年均增长率为10.52%，推动因素包括技术进步、癌症发病率增加和对非侵入性诊断的需求。
到2035年，液体活检市场预计将成为癌症诊断的关键组成部分。
The market is projected to reach 27.34 USD Billion by 2035.
The Oncology application segment is expected to grow from 4.5 USD Billion to 13.5 USD Billion by 2035.
The Non-Oncology segment is projected to expand from 2.0 USD Billion to 6.0 USD Billion, while Prenatal Testing is expected to grow from 1.0 USD Billion to 3.0 USD Billion.
Blood is anticipated to be the leading sample type, growing from 3.5 USD Billion to 10.5 USD Billion by 2035.
Next Generation Sequencing is projected to increase from 2.73 USD Billion to 8.12 USD Billion during the forecast period.
Hospitals are expected to grow from 2.73 USD Billion to 8.12 USD Billion, indicating their significant role as end users.
Key players include Guardant Health, Exact Sciences, GRAIL, Freenome, and Roche Diagnostics.
The Diagnostic Laboratories segment is expected to grow from 2.27 USD Billion to 6.81 USD Billion by 2035.
Introduction
The research methodology for the “Liquid Biopsy Market - Global Analysis and Forecasts” report is presented in this section. This research aims to provide in-depth insights into the global liquid biopsy market, by analyzing its current and projected performance concerning competitive market forces. This report provides an overview of the industry, market drivers and inhibitors influencing the market growth, competitive dynamics and key chapters of the market in terms of market segmentation and applications.
Research Approach
In order to collect information on market trends, drivers and inhibitors, the research process includes extrapolating the data and insights derived from second-party resources such as published reports, corporate websites, and public datasets. The prognosis of the global liquid biopsy market is established by balancing the vital qualitative and quantitative information which is obtained through primary interviews with Market Experts and Thought Leaders, as well as via extensive literature reviews including secondary sources such as directories, industry journals, white papers, technical papers, press releases, corporate annual reports from top players.
Moreover, market forecasts and projections are established by using advanced econometric techniques and models. The research process is divided into five sections – Primary & Secondary Exploration, Mapping of Market Opportunities, Market Assessments & Projections and Validation of Model Assumptions.
Scope of the Report
The report includes the landscape of the global liquid biopsy market, its size by value, by region and by end-user, competitive landscape and competitive strategies adopted by key players, market dynamics such as drivers, restraints, opportunities and challenges, new technological advancements and recent launches and future market trends. The notable market players included in the report comprise Genomic Health Inc., Life Technologies Corporation, Biocept Inc., Biodesix Inc., Cepheid, Cynvenio Biosystems Inc., Exosome Life Sciences, HTG, MDxHealth Ltd., Myriad Genetics Inc., and Trovagene Inc. In all, 17 company profiles have been included in the report.
Research Methodology
The research methodology for the liquid biopsy market is based on both primary and secondary research. For the primary research, a structured questionnaire is sent to industry experts, including key opinion leaders and thought leaders, who provided their insights and views on the market. In addition, macro- and micro-economic indicators of the industry are considered for arriving at the expected market growth during the forecast period. The secondary research is done using extensive research methodologies and in-depth analysis of published market reports and content from paid databases, journals and other third-party resources. The market data is also validated with proprietary analytics tools and models.
The market is segmented into product types, applications, end-users, geographies and key countries and stakeholders. Primary interviews are conducted to ascertain the market estimates and confirm the assumptions based on secondary and primary research. The report covers a geographic segmentation of the liquid biopsy market along with competitor analysis for key countries/regions such as North America (US, Canada, Mexico and the Rest of North America), Europe (The UK, Germany, France, Rest of Europe), Asia-Pacific (India, China, Japan, Rest of Asia Pacific) and Rest of the world (Middle East & Africa, Latin America).
Market Estimation
The global liquid biopsy market is estimated considering historical data and various market dynamics such as market drivers, opportunities and challenges. Thereafter, calculated values have been derived through an exhaustive triangulation method. All these factors are studied, analyzed, considered and weighted to arrive at the estimated values, which help to forecast the market position in terms of CAGR, size and other important parameters.
Data Sources
The data points considered to come up with the market estimates and forecasts include secondary research, databases and primary research (which includes interviews and surveys). The data points were aggregated and the resultant values were checked and validated using proprietary analytics models.
Customization
The report can be customized as per the requirements of the clients. Based on detailed analysis and insights into the market, customized deliveries on the research report are provided including company-specific analysis, regional-specific analysis and segment-specific analysis.
请填写以下表格以获取本报告的免费样本
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”
